Thrivent Financial for Lutherans lessened its stake in Cushman & Wakefield plc (NYSE:CWK – Free Report) by 23.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,102,399 shares of the company’s stock after selling 1,870,229 shares during the period. Thrivent Financial for Lutherans owned 2.66% of Cushman & Wakefield worth $83,176,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Blue Trust Inc. increased its position in shares of Cushman & Wakefield by 137.5% during the third quarter. Blue Trust Inc. now owns 3,501 shares of the company’s stock worth $48,000 after acquiring an additional 2,027 shares during the period. GAMMA Investing LLC increased its holdings in Cushman & Wakefield by 45.8% during the 3rd quarter. GAMMA Investing LLC now owns 5,186 shares of the company’s stock worth $71,000 after purchasing an additional 1,629 shares during the period. CWM LLC raised its position in Cushman & Wakefield by 61.4% during the 2nd quarter. CWM LLC now owns 5,468 shares of the company’s stock valued at $57,000 after purchasing an additional 2,080 shares in the last quarter. KBC Group NV lifted its holdings in shares of Cushman & Wakefield by 31.7% in the 3rd quarter. KBC Group NV now owns 7,961 shares of the company’s stock worth $109,000 after buying an additional 1,915 shares during the period. Finally, Profund Advisors LLC bought a new position in shares of Cushman & Wakefield during the 2nd quarter worth $105,000. Institutional investors own 95.56% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts recently weighed in on the company. JPMorgan Chase & Co. lifted their price objective on Cushman & Wakefield from $12.00 to $14.00 and gave the company a “neutral” rating in a report on Tuesday, July 30th. Raymond James upped their price target on shares of Cushman & Wakefield from $14.00 to $16.00 and gave the stock an “outperform” rating in a research report on Thursday, July 25th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $12.80.
Cushman & Wakefield Stock Performance
Shares of Cushman & Wakefield stock opened at $13.84 on Monday. The company has a market capitalization of $3.18 billion, a PE ratio of 37.41 and a beta of 1.30. The company has a 50-day simple moving average of $13.41 and a two-hundred day simple moving average of $12.19. Cushman & Wakefield plc has a one year low of $8.09 and a one year high of $16.11. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.18 and a current ratio of 1.18.
Cushman & Wakefield (NYSE:CWK – Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.21 by $0.02. The firm had revenue of $2.34 billion during the quarter, compared to analyst estimates of $1.61 billion. Cushman & Wakefield had a net margin of 0.94% and a return on equity of 12.10%. Cushman & Wakefield’s revenue was up 2.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.21 EPS. Research analysts expect that Cushman & Wakefield plc will post 0.86 EPS for the current fiscal year.
Cushman & Wakefield Company Profile
Cushman & Wakefield plc, together with its subsidiaries, provides commercial real estate services under the Cushman & Wakefield brand in the United States, Australia, the United Kingdom, and internationally. The company operates through Americas; Europe, Middle East and Africa; and Asia Pacific segments.
Read More
- Five stocks we like better than Cushman & Wakefield
- Canadian Penny Stocks: Can They Make You Rich?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Differences Between Momentum Investing and Long Term Investing
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Cushman & Wakefield Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cushman & Wakefield and related companies with MarketBeat.com's FREE daily email newsletter.